Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT06529731 · RECRUITING
Trial details
- NCT number
- NCT06529731
- Sponsor
- Sawa Ito, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-23
- Primary completion
- 2029-10-31
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.